SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital.

Ferrari, Davide; Clementi, Nicola; Mancini, Nicasio; Locatelli, Massimo

Ferrari, Davide; Clementi, Nicola; Mancini, Nicasio; Locatelli, Massimo.

Ferrari D; SCVSA Department, University of Parma, Parma, Italy. Electronic address: davide.ferrari@unipr.it.
Clementi N; Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy; IRCCS Ospedale San Raffaele, Milan, Italy.
Mancini N; Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy; IRCCS Ospedale San Raffaele, Milan, Italy.
Locatelli M; IRCCS Ospedale San Raffaele, Milan, Italy.

Clin Microbiol Infect ; 28(2): 305-307, 2022 02.

Article in English | MEDLINE | ID: covidwho-1654232

Subject(s)

COVID-19; Vaccines; Antibodies, Neutralizing; Antibodies, Viral; Hospitals; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google